Sequenom Updates Fiscal 2015 Revenue Outlook - Quick Facts

(RTTNews) - Life sciences company Sequenom, Inc. (SQNM) said it is updating its revenue expectations for the second half of the year to a range of $57 million to $61 million, bringing 2015 annual revenue expectations to a range between $127 million and $131 million.

On average, four analysts polled by Thomson Reuters expect the company to report revenues of $141.04 million for the year. Analysts' estimates typically exclude special items.

The company updated the revenue guidance citing increased competition and price compression in the noninvasive prenatal testing (NIPT) market.

The Company said it expects to announce its financial results for the third quarter on November 4, 2015, and will provide further discussion of its operating results at that time.